Institute for Safe Medication Practices

Among others, ISMP maintains and disseminates a list of "do not crush" medications,{{Cite journal|last=Cohen|first=Michael R.|date=July 2007|title="Do Not Crush" list|url=https://dx.doi.org/10.1097/01.NURSE.0000279404.54880.3a|journal=Nursing2021|language=en-US|volume=37|issue=7|pages=12|doi=10.1097/01.NURSE.0000279404.54880.3a|issn=0360-4039|url-access=subscription}} as well as clinical best practices.{{Cite web|title=ISMP Publishes 2020-2021 Consensus-Based Medication Safety Best Practices for Hospitals|url=https://www.ismp.org/news/ismp-publishes-2020-2021-consensus-based-medication-safety-best-practices-hospitals|access-date=2021-06-30|website=Institute For Safe Medication Practices|date=27 February 2020 |language=en}} The ISMP's Medication Safety Self-Assessment tool has been used in surveys of medication safety in hospitals in the United States and elsewhere.{{Cite journal |last1=Lesar |first1=Timothy |last2=Mattis |first2=Arnold |last3=Anderson |first3=Ernest |last4=Avery |first4=Jean |last5=Fields |first5=John |last6=Gregoire |first6=Jill |last7=Vaida |first7=Allen |author8=VHA New England Medication Error Prevention Initiative Collaborative |date=2003-05-01 |title=Using the ISMP Medication Safety Self-Assessment™ to Improve Medication Use Processes |url=https://www.sciencedirect.com/science/article/abs/pii/S1549374103290262 |journal=The Joint Commission Journal on Quality and Safety |language=en |volume=29 |issue=5 |pages=211–226 |doi=10.1016/S1549-3741(03)29026-2 |issn=1549-3741 |pmid=12751302 |via=Elsevier Science Direct|url-access=subscription }}{{Cite journal|date=2014-02-01|title=Assessing the State of Safe Medication Practices Using the ISMP Medication Safety Self Assessment® for Hospitals: 2000 and 2011|url=https://www.sciencedirect.com/science/article/abs/pii/S1553725014400072|journal=The Joint Commission Journal on Quality and Patient Safety|language=en|volume=40|issue=2|pages=51–AP3|doi=10.1016/S1553-7250(14)40007-2|issn=1553-7250|last1=Vaida|first1=Allen J.|last2=Lamis|first2=Rebecca L.|last3=Smetzer|first3=Judy L.|last4=Kenward|first4=Kevin|last5=Cohen|first5=Michael R.|pmid=24716328|url-access=subscription}}{{Cite journal |last1=Greenall |first1=Julie |last2=Shastay |first2=Ann |last3=Vaida |first3=Allen J |last4=U |first4=David |last5=Johnson |first5=Philip E |last6=O’Leary |first6=Joe |last7=Chambers |first7=Carole |date=2015-02-01 |title=Establishing an international baseline for medication safety in oncology: Findings from the 2012 ISMP International Medication Safety Self Assessment® for Oncology |url=https://doi.org/10.1177/1078155214556522 |journal=Journal of Oncology Pharmacy Practice |language=en |volume=21 |issue=1 |pages=26–35 |doi=10.1177/1078155214556522 |issn=1078-1552 |pmid=25361598 |s2cid=36967892|url-access=subscription }}{{Cite journal |last1=McCarthy |first1=Kaitlyn R. |last2=Christakos |first2=Eugenia |last3=Kurzatkowski |first3=Amy |last4=Gernant |first4=Stephanie A. |date=2021-07-01 |title=Characterizing perceptions of an abbreviated ISMP Medication Safety Self Assessment for community pharmacies |journal=Journal of the American Pharmacists Association |language=en |volume=61 |issue=4 |pages=S105–S117 |doi=10.1016/j.japh.2021.02.013 |issn=1544-3191 |pmid=33812781 |s2cid=233029198|doi-access=free }}

The ISMP frequently investigates and reports on medication errors that have occurred in practice. These investigations are often published in the peer-reviewed journal Hospital Pharmacy.{{Cite journal|last1=Mancano|first1=Michael A.|last2=Esordi|first2=Morgan V.|last3=Patel|first3=Darshil D.|last4=Milenki|first4=Kristen J.|date=2019-04-01|title=ISMP Adverse Drug Reactions: Longitudinal Thumbnail Fissures Due to Erlotinib Priapism Associated With the Use of ExtenZe Blindness From a Nevirapine-Based HAART Regimen Hyperprolactinemia and Galactorrhea Due to Aripiprazole Trypophobia Associated With Gabapentin Coadministered Linezolid and Methadone Cause Serotonin Syndrome|url=https://doi.org/10.1177/0018578718824449|journal=Hospital Pharmacy|language=en|volume=54|issue=2|pages=88–92|doi=10.1177/0018578718824449|issn=0018-5787|pmc=6431722|pmid=30923400}}{{Cite journal|last=Mancano|first=Michael A.|date=2018-02-01|title=ISMP Adverse Drug Reactions: Influenza Vaccine–Induced Stevens-Johnson Syndrome; Vilazodone-Induced Nightmares; Dabigatran-Induced Pustular Eruptions; Neurotoxic and Cardiotoxic Symptoms After Cannabis Concentrate Exposure; Rosuvastatin-Induced Skin Eruption|url=https://doi.org/10.1177/0018578717739727|journal=Hospital Pharmacy|language=en|volume=53|issue=1|pages=15–17|doi=10.1177/0018578717739727|issn=0018-5787|pmc=5805017|pmid=29434381}}{{Cite journal|last1=Mancano|first1=Michael A.|last2=Lapin|first2=Jonathan|last3=Paik|first3=Andrew|date=2019-08-01|title=ISMP Adverse Drug Reactions: Pheochromocytoma Crisis Induced by Metoclopramide Baclofen Dependence Following High-Dose Therapy Fatal Cardiotoxicity Following High-Dose Cyclophosphamide Acute Anterograde Amnestic Syndrome Induced by Fentanyl Ivermectin-Induced Toxic Epidermal Necrolysis Pembrolizumab-Induced Type 1 Diabetes|url=https://doi.org/10.1177/0018578719828860|journal=Hospital Pharmacy|language=en|volume=54|issue=4|pages=241–245|doi=10.1177/0018578719828860|issn=0018-5787|pmc=6628555|pmid=31320773}}

{{Reflist}}

{{Authority control}}

Category:Pharmacology

Category:Drug safety

Category:Patient safety

{{Pharma-stub}}